Related references
Note: Only part of the references are listed.Anticancer Activity of Metal Complexes: Involvement of Redox Processes
Ute Jungwirth et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Comparative Solution Equilibrium Study of the Interactions of Copper(II), Iron(II) and Zinc(II) with Triapine (3-Aminopyridine-2-carbaldehyde Thiosemicarbazone) and Related Ligands
Eva A. Enyedy et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2010)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
Antioxidative properties of copper(II) complexes
Alicia M. Diaz et al.
JOURNAL OF COORDINATION CHEMISTRY (2009)
Impact of Metal Coordination on Cytotoxicity of 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone (Triapine) and Novel Insights into Terminal Dimethylation
Christian R. Kowol et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors
Yu Yu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine((R))) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders
Judith E. Karp et al.
LEUKEMIA RESEARCH (2008)
A short history of SHELX
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
A ferrous-Triapine complex mediates formation of reactive oxygen species chat inactivate human ribonucleotide reductase
JM Shao et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Copper in medicine: Homeostasis, chelation therapy and antitumor drug design
T Wang et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia
FJ Giles et al.
LEUKEMIA RESEARCH (2003)
Platinum(IV) antitumour compounds: their bioinorganic chemistry
MD Hall et al.
COORDINATION CHEMISTRY REVIEWS (2002)
DNA-fiber EPR study of the orientation of Cu(II) complexes of 1,10-phenanthroline and its derivatives bound to DNA: mono(phenanthroline)-copper(II) and its ternary complexes with amino acids
M Chikira et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2002)
Biological activity of complexes derived from pyridine-2-carbaldebyde thiosemicarbazone -: Structure of [Co(C7H7N4S)2][NCS]
J García-Tojal et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2001)